COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

OR Kaitlyn Kelley

Welcome to the Division of Surgical Oncology

The Division of Surgical Oncology is at the forefront of treatment for patients with breast, GI stromal tumor, hepatobiliary-pancreatic, and peritoneal malignancies. Our faculty are active in basic and clinical research, funded by the National Institutes of Health/National Cancer Institute, the Veteran's Administration, and Stand Up to Cancer, among others. Most of these studies use molecularly targeted or other novel therapeutics not offered anywhere else in the nation.


UC San Diego Health Expands Leading-Edge Cancer Care in Hillcrest

To make it easier for patients to receive world-class care from San Diego's only National Cancer Institute-Designated Comprehensive Cancer Center, UC San Diego Health has added a new multidisciplinary cancer clinic in Hillcrest, staffed with physicians who specialize in some of the most commonly diagnosed malignancies.. 

Read More

Stand Up To Cancer

Surgeon-scientists in UC San Diego's Department of Surgery are advancing efforts to fight the disease for tomorrow's patients, while providing the best possible care for today's patients. A team of UC San Diego researchers and physicians, co-led by Dr. Andrew Lowy, Chief of the Division of Surgical Oncology, was recently awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer. This is the third SU2C grant targeting pancreatic cancer to be awarded to UC San Diego researchers.